IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 37 filers reported holding IMPEL NEUROPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $54,026 | -16.9% | 14,407 | +7.5% | 0.01% | -16.7% |
| Q3 2022 | $65,000 | -48.0% | 13,407 | 0.0% | 0.01% | -50.0% |
| Q2 2022 | $125,000 | +47.1% | 13,407 | 0.0% | 0.01% | +71.4% |
| Q1 2022 | $85,000 | -26.7% | 13,407 | 0.0% | 0.01% | -46.2% |
| Q4 2021 | $116,000 | -28.8% | 13,407 | 0.0% | 0.01% | -18.8% |
| Q3 2021 | $163,000 | – | 13,407 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NVP Associates, LLC | 3,077,198 | $1,323,195 | 1.18% |
| 5AM Venture Management, LLC | 2,884,791 | $1,240,460 | 0.36% |
| venBio Partners LLC | 2,759,791 | $1,186,710 | 0.34% |
| Vivo Capital, LLC | 2,884,789 | $1,240,459 | 0.14% |
| LASRY MARC | 225,874 | $97,126 | 0.10% |
| Kohlberg Kravis Roberts & Co. L.P. | 4,135,971 | $1,778,468 | 0.06% |
| DCF Advisers, LLC | 178,500 | $76,755 | 0.04% |
| EPIQ PARTNERS, LLC | 16,325 | $7,020 | 0.01% |
| MCDONALD PARTNERS LLC | 19,400 | $8,342 | 0.00% |
| XTX Topco Ltd | 21,222 | $9,125 | 0.00% |